The isolation was realized by liquid chromatography using a multistage fractionation approach. The crude extract was subjected to prefractionation by MPLC using a double injection with total injected weight of 85.0 g per injection. The parameters used for the MPLC are given in Table S-I. Nine prefractions (A-I) were collected starting at time 10 min. After the start, fractions were collected at 8 min intervals. The obtained prefractions were tested on human fibroblastlike synoviocyte cell line SW982 to determine any effect on PLA 2 activity by measuring the release of AA. Three very active prefractions were found that were subsequently fractionated into 259 fractions by 3 respective separations on preparative HPLC. The parameters used for preparative HPLC separation are given in Table S-II. A total of 80 fractions from prefraction E, 90 fractions from prefraction F and 89 fractions from prefraction G were obtained. The injected amounts of prefractions E, F and G were 2.3638, 0.7078 and 1.0822 g respectively, at a flow rate of 109 mL min -1 . All fractionations were based on time, 18 to 20 s per fraction. All the obtained fractions were tested for inhibition of PLA 2 activity by measuring the release of AA. Based on the similarity of chroma-* , ** Corresponding authors.
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